Prevalence of and Risk Factors for Oral Human Papillomavirus Among Young Women in Costa Rica
Authors:
- Krystle A. Lang KuhsKKKrystle A. Lang Kuhs
- Linda StruijkLSLinda Struijk
- Allan HildesheimAHAllan Hildesheim
- Leen-Jan van DoornLDLeen-Jan van Doorn
- Mark SchiffmanMSMark Schiffman
- Wim QuintWQWim Quint
- Douglas R. LowyDLDouglas R. Lowy
- Carolina PorrasCPCarolina Porras
Open Access
- 6 September 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 208 (10) , 1643-1652
Abstract
Background. Little is known about the epidemiology of oral human papillomavirus (HPV) in Latin America. Methods. Women (N = 5838) aged 22–29 in the control and vaccine arms of an HPV-16/18 vaccine trial in Costa Rica had oral, cervical, and anal specimens collected. Samples were tested for alpha mucosal HPV types (SPF10/LiPA25 version 1); a subset of oral samples (n = 500) was tested for cutaneous HPV types in the genera alpha, beta, gamma, mu, and nu. Results. In the control arm (n = 2926), 1.9% of women had an oral alpha mucosal HPV detected, 1.3% had carcinogenic HPV, and 0.4% had HPV-16; similar patterns for non-16/18 HPV types were observed in the vaccine arm. Independent risk factors for any oral alpha mucosal HPV among women in the control arm included marital status (adjusted odds ratio [AOR], 3.2; 95% confidence interval [CI], 1.8–5.7 for single compared to married/living as married), number of sexual partners (AOR, 2.4; 95% CI, 1.0–6.1 for ≥4 partners compared to 0–1 partners), chronic sinusitis (AOR, 3.1; 95% CI, 1.5–6.7), and cervical HPV infection (AOR, 2.6; 95% CI, 1.4–4.6). Detection of beta HPV was common (18.6%) and not associated with sexual activity. Conclusions. Unlike cutaneous HPV types, alpha mucosal HPV types were uncommon in the oral region and were predominately associated with sexual behavior. Clinical Trials Registration. NCT00128661.Keywords
This publication has 39 references indexed in Scilit:
- The Oral Cavity Contains Abundant Known and Novel Human Papillomaviruses From the Betapapillomavirus and Gammapapillomavirus GeneraThe Journal of Infectious Diseases, 2011
- Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancersBritish Journal of Cancer, 2011
- The Epidemiology of Oral HPV Infection among a Multinational Sample of Healthy MenCancer Epidemiology, Biomarkers & Prevention, 2011
- Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985–2006The Annals of The Royal College of Surgeons of England, 2010
- Evaluation of a Novel Broad-Spectrum PCR-Multiplex Genotyping Assay for Identification of Cutaneous Wart-Associated Human Papillomavirus TypesJournal of Clinical Microbiology, 2010
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendmentsVirology, 2010
- Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in SpainBMC Infectious Diseases, 2009
- Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa RicaVaccine, 2008
- Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCRJournal of Clinical Microbiology, 2006
- Evaluation of a Novel Highly Sensitive, Broad-Spectrum PCR-Reverse Hybridization Assay for Detection and Identification of Beta-Papillomavirus DNAJournal of Clinical Microbiology, 2006